Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Tardif, J.-C.
Right arrow Articles by Joyal, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tardif, J.-C.
Right arrow Articles by Joyal, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Chronic heart rate reduction with ivabradine and prevention of atherosclerosis progression assessed using intravascular ultrasound

J.-C. Tardif*, J. Grégoire, P.L. Lallier and M. Joyal

Department of Medicine, Montreal Heart Institute, Montreal, Canada

* Jean-Claude Tardif, MD, Montreal Heart Institute, 5000 Belanger Street East, Montreal, Quebec, Canada, H1T 1C8.

Abstract

Experimental data have shown that reduction in atherosclerosis progression can be obtained through chronic heart rate reduction. Heart rate is significantly correlated with the severity and progression of atherosclerosis on coronary angiography in patients. Limitation of the progression of atherosclerosis may therefore become an important therapeutic target of the specific heart rate reducing agent ivabradine. The ability of intravascular ultrasound (IVUS) to assess plaque burden precisely makes it the ideal tool for a clinical trial of progression and regression of atherosclerosis. The present article provides an overview of the design and of some methodological features of a clinical trial to assess the effects of ivabradine on the progression of coronary atherosclerosis, as assessed by IVUS.

Key Words: Atherosclerosis • Coronary artery disease • Heart rate reduction • Intravascular ultrasound • Sinoatrial node


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.